Skip to main content

Fibromyalgia/Pain

      Fibromyalgianess Glucocorticoid Persistence in RA Patients: Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract #0120 pr

      Dr. John Cush RheumNow

      3 years 6 months ago
      Fibromyalgianess Glucocorticoid Persistence in RA Patients: Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract #0120 presented at the #ACR21 annual meeting. https://t.co/9yOM5rSARv https://t.co/Gq2YxbxkmM
      The Last CBD Trial: Dr. David Liew
      RT @Janetbirdope: Interesting results where cannabidiol NEG results in RCT in hand OA and PsA. ? Throw out the ‘pot’

      Janet Pope Janetbirdope

      3 years 6 months ago
      Interesting results where cannabidiol NEG results in RCT in hand OA and PsA. ? Throw out the ‘pot’with the dish water? Did it stimulate appetites? Was pain the same but interference less? Abst#1456 #ACR21 @RheumNow https://t.co/rnz82Paxkr
      RT @ericdeinmd: #ACR21 Ab#1166. How many of your pts use marijuana?
      ⭐️Probably more than you think!
      ▶️57% have t

      Eric Dein ericdeinmd

      3 years 6 months ago
      #ACR21 Ab#1166. How many of your pts use marijuana? ⭐️Probably more than you think! ▶️57% have tried, >50% use at least weekly ▶️67% doctors thought <20% of pts use it 🔥Pts over 40 yo MORE likely to report marijuana use @Rheumnow https://t.co/0uW8rZvf1k https://t.co/ShMnR0faHr
      In a world where telemedicine and virtual care are not going away, is there value in patients assessing their own tender and swollen joints? Work from the Canadian Early Arthritis Cohort (CATCH, @earlyarthritis) presented by Dr. Vivian Bykerk (@BykerkVivian) is the subject of two abstracts from Monday’s poster floor, exploring the utility as to how patient assessments might match up to rheumatologist assessments.
      ACR21 Daily Recap Day 1
      RT @RichardPAConway: Sublingual Cyclobenzaprine for fibromyalgia. It seems to improve pain, and across the board on seco

      Richard Conway RichardPAConway

      3 years 7 months ago
      Sublingual Cyclobenzaprine for fibromyalgia. It seems to improve pain, and across the board on secondary endpoints. But all by a modest effect. Big placebo response also. Not time to get overly excited yet. Abstr#0477 #ACR21 @RheumNow https://t.co/aUtwaH5oEh
      ×